Develop a digital learning companion to provide treatment options based on protein insights for patients with rare and complex cancers lacking genome-targeted therapies, laying the foundation for artificial intelligence (AI)-assisted precision oncology and its integration into clinical research
The interdisciplinary research teams comprise 65 researchers who represent six colleges and schools at UT Austin and 20 departments at MD Anderson. Each team will receive up to $4.5 million to carry out its work. More details about each research project can be found here.
MD Anderson ranks as one of the world’s most respected centers focused on cancer patient care, research, education and prevention. UT Austin, a top public research university, is renowned for its capabilities in high performance computing, computational modeling and artificial intelligence, particularly at the intersection of medical research.
Ad Statistics
Times Displayed: 18753
Times Visited: 357 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The Accelerator program builds on complementary expertise and a shared vision between the two institutions to transform cancer care, expanding upon ongoing strategic collaborations between MD Anderson and UT Austin that are providing opportunities for joint cancer research projects with unprecedented scope.
For example, the Joint Center for Computational Oncology – which includes UT Austin’s Oden Institute for Computational Engineering and Sciences and Texas Advanced Computing Center (TACC) and MD Anderson – brings together oncology, data and computational science, and high-performance computing strengths to support innovative research. The initiative has generated discoveries of several new clinical approaches for cancer treatment as well as novel insights for improving outcomes for patients with unmet needs.
These collaborations will be fortified and amplified through the development of The University of Texas at Austin Medical Center, announced by The University of Texas System in 2023. The medical center, on the former site of the Frank Erwin Center, will house a comprehensive cancer center built and operated by MD Anderson as well as a tertiary hospital built and operated by UT Austin. The new facilities are expected to open in 2030.
Back to HCB News
